Advisor Group Holdings, Inc. Cardiol Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,289 shares of CRDL stock, worth $5,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,289

Previous 3,744 14.56%

Holding current value

$5,704

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.96 - $1.46 $523 - $795	545 Added 14.56%	4,289 $4,000
Q4 2024 Jun 06, 2025	SELL	$1.25 - $2.07 $681 - $1,128	-545 Reduced 12.71%	3,744 $4,000
Q4 2024 Feb 07, 2025	BUY	$1.25 - $2.07 $3,180 - $5,266	2,544 Added 212.0%	3,744 $4,000
Q2 2024 Aug 13, 2024	SELL	$1.67 - $2.97 $40,748 - $72,468	-24,400 Reduced 95.31%	1,200 $2,000
Q1 2024 May 10, 2024	SELL	$0.88 - $2.06 $36,256 - $84,872	-41,200 Reduced 61.68%	25,600 $46,000
Q4 2023 Feb 12, 2024	SELL	$0.67 - $1.0 $1,340 - $2,000	-2,000 Reduced 2.91%	66,800 $56,000
Q3 2023 Nov 13, 2023	BUY	$0.76 - $1.19 $1,520 - $2,380	2,000 Added 2.99%	68,800 $61,000
Q2 2023 Aug 10, 2023	BUY	$0.45 - $0.97 $13,500 - $29,100	30,000 Added 81.52%	66,800 $59,000
Q1 2023 May 12, 2023	SELL	$0.47 - $0.81 $17,817 - $30,707	-37,910 Reduced 50.74%	36,800 $18,000
Q4 2022 Feb 10, 2023	BUY	$0.48 - $1.0 $24,897 - $51,870	51,870 Added 227.1%	74,710 $38,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $1.41 $68,813 - $95,124	-67,464 Reduced 74.71%	22,840 $24,000
Q2 2022 Aug 10, 2022	SELL	$1.03 - $2.05 $23,436 - $46,645	-22,754 Reduced 20.13%	90,304 $120,000
Q1 2022 May 04, 2022	BUY	$1.25 - $2.31 $121,572 - $224,665	97,258 Added 615.56%	113,058 $173,000
Q3 2021 Nov 05, 2021	BUY	$2.03 - $4.8 $32,073 - $75,840	15,800 New	15,800 $65,000

Others Institutions Holding CRDL

# of Institutions

Shares Held

7.81M

Call Options Held

25.9K

Put Options Held

1.7K

View Full List

About Cardiol Therapeutics Inc.

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $82.4M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

More about CRDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Cardiol Therapeutics Inc. Transaction History